Evidence map›Paper›PMID 25352052›Full record

ArticleJournal of clinical immunology2015

Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).

Maguy Daures, Michele John, Cécile Veysseyre Balter, Olivier Simon, Yann Barguil, Isabelle Missotte, Jean-Paul Grangeon, Sylvie Laumond-Barny, Martine Noel, Laurent Besson-Leaud and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Maguy DauresPublic Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia. maguy.daures@gmail.com.
Michele JohnPublic Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia.
Cécile Veysseyre BalterLaboratory of Immunology, Team 2267, Claude Bernard University, Lyon, France.
Olivier SimonNeurology Department, Noumea Territorial Hospital, Noumea, New Caledonia.
Yann BarguilBiochemistry and Haemostasis Laboratory, Noumea Territorial Hospital, Noumea, New Caledonia.
Isabelle MissottePaediatrics Department, Noumea Territorial Hospital, Noumea, New Caledonia.
Jean-Paul GrangeonPublic Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia.
Sylvie Laumond-BarnyPublic Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia.
Martine NoelPublic Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia.
Laurent Besson-LeaudPaediatrics Department, Noumea Territorial Hospital, Noumea, New Caledonia.
Pierre-Emmanuel SpasicDepartment of Internal Medicine, Noumea Territorial Hospital, Noumea, New Caledonia.
Aurélie de SuremainPaediatrics Department, Noumea Territorial Hospital, Noumea, New Caledonia.
Ann-Claire GourinatLaboratory of Serology and Molecular Diagnosis, Pasteur Institute, Noumea, New Caledonia.
Elodie DesclouxDepartment of Internal Medicine, Noumea Territorial Hospital, Noumea, New Caledonia.
Centre Hospitalier Territorial de Nouvelle-Calédonie · NCUniversity of New Caledonia · NCInstitut Pasteur de Nouvelle Calédonie · NCUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInvasive Meningococcal Disease (IMD) is three fold more common in New Caledonia (NC) than in metropolitan France and many IMD cases (35.7%) are due to Y and W135 serogroups. The purpose of our study was to identify IMD risk factors in NC.

methodsA retrospective study of all IMD cases that occurred in NC between 2005 and 2011 was conducted. Socio-environmental, clinical and biological data were collected. A search for immune deficiency was proposed to all cases. IMD presentation and outcome were compared according to meningoccal serogroups and the complement deficiency status (C-deficiency).

resultsSixty-six sporadic IMD cases (29 B serogroup, 20 Y or W135, 6 C, 1 A, 10 unknown) occurred in 64 patients often <24 years-old and of Melanesian origin. Five patients died (7.8%). No socio-environmental risk factors were identified. No asplenia, HIV infection or immunoglobulin deficiencies were found. Two patients had diabetes and 28 of 53 (52.8%) patients had C-deficiency including 20 (71.4%) cases of late complement component deficiency. Patients with C-deficiency were mainly Melanesian (92.8%) originating from the Loyalty Islands (62.1%). They were mostly infected with Y/W135 (42.9%) or B serogroups (32.1%). They often developed later and more severe disease than patients without C-deficiency (need for intensive cares in 60% versus 28.0% of cases, p = 0.01).

conclusionsA high prevalence of C-deficiency in the Melanesian population may explain epidemiological and clinical features of IMD in NC. Our results imply an adaptation of meningococcal vaccine strategies in NC.

Indexed as

AdolescentAdultAgedAged, 80 and overBacteremiaChildChild, PreschoolComplement System ProteinsFemaleHumansInfantMaleMeningitis, MeningococcalMeningococcal InfectionsMiddle AgedNeisseria meningitidis, Serogroup BComplement System ProteinsComplement deficiencymelanesian populationmeningococcal diseaserisk factors

Identifiers

PMID25352052
OpenAlexW2056815236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.